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S_nmary The characteristics of cervicography and the Papamncolaou smear test have been compared for the
detection of cervix lesions classified as CIN I or more. A total of 4,015 women were entered into the study.
The sensitivity of cervicography is significantly higher (McNemar test, P<0.0001), but its specificity remains
significantly lower (McNemar test, P<0.0001), and its higher sensitivity does not apply to lesions classified as
CIN II or more (high-grade lesions). Hence, if patients with a positive screen result are to be referred for
colposcopy-biopsy, cervicography is not a suitable alternative to the smear test for the screening of cervical
cancer. However, cervicography can be envisaged as a complementary tool to the smear test because of (a) its
higher capability to detect high-grade lesions among women less than 35 years old and (b) its potential
superiority in following low-grade lesions. It may also serve as a tool for quality assurance audit of the smear
test.
Screening with the Papanicolaou smear test has succeeded in
decreasing substantially the incidence of cervical cancer in
countries where the screening programme is well organised,
i.e. where the majonrty of the target population is tested and
where high standards of cell sampling and reading are
achieved (IARC, 1986; Laara et al., 1987; Day, 1989).
Cervicography as a means of screening was introduced by
Stafl at the beginning of the 1980s (Stafl, 1981). The initial
aim was to provide a cheap alternative to routine colposcopy
in the screening for cervical cancer.
This technique consists in taking pictures (diapositive slides
called 'cervicograms') (Coppleson et al., 1992) with a special
reflex camera after application of acetic acid 5%. The tech-
nique can be performed by a general practitioner or a nurse.
Cervicograms are projected onto a screen with magnification,
and abnormalities are then sought as for a colposcopic
evaluation. However, unlike colposocpy, the method provides
permanent documentation of the appearance of the cervix.
We started to evaluate this method 3 years ago. The object
of this article is to compare the performance of cytology and
cervicography for screening of cervical precancerous
lesions.
Materials and metbods
Screeningprocedure
The comparison was performed on 4,095 consecutive women
20 years old or more seen at the screening clinic of the Jules
Bordet Institute from July 1989 until September 1990. These
women were healthy and without gynaecological complaints.
The majority had had one or more smear tests in the past,
hence the lesions found were a mixture of prevalent and
incident cases.
All women simultaneously underwent an exo- and endocer-
vical smear and cervicography, both performed by general
practitioners. The assessments of cervicograms and of
cytological specimens were separate processes without any
mutual influence. Women positive for either cytology or
cervicography were recalled for colposcopic-directed biopsies
of all abnormal areas. Women with negative screening results
on both tests were not recalled.
Cervicographk, cytological and histopathological classification
Positive screening tests and histopathological results were
graded according to the C[N classification: CIN I, II, III or
cancer. Since cytology and cervicography cannot distinguish
between CIN I and flat condylomatous lesions, images sug-
gestive of an infection by papillomavirus were included in the
CIN I category.
Screening results qualified as 'atypical' or 'trivial change'
were considered to be negative tests. CIN I lesions were
considered to be low-grade lesions. CIN II or higher lesions
were considered to be high-grade lesions. This distinction is
based on the fact that there is a wide consensus that patients
with CIN II or higher grade lesions should be subjected to
further investigations, whereas the follow-up of CIN I lesions
is still controversial (Ellman, 1991; Miller et al., 1991).
The reference test was the histopathological examination of
the biopsy specimens. All pathology slides were read by two
pathologists, each unaware of the evaluation done by the
other. In case of disagreement between the two readers, the
final diagnosis was established by a senior pathologist aware
of the two previous reports.
Statistical analysis
True-positive results are considered from two perspectives:
(a) the positive screening test yielding a pathology specimen
classified as CIN I, II, III or carcinoma; (b) the positive
screening test yielding a pathology specimen classified as a
high-grade lesion. These two perspectives allow the weight of
the low-grade lesions within the results to be appreciated and
the capacity of a screening test to detect high-grade lesions to
be assessed.
True- and false-negative results could not be differentiated
since the reference test (i.e. the biopsy) was not applied to
screen-negative women. Hence, sensitivity and specificity
could not be calculated directly. To overcome this metho-
dological hindrance, we computed the parameters proposed
to compare two tests when the reference procedure is not
applicable to women with a negative screening test (Mor-
rison, 1985; Brecht & Robra, 1987; Shatzkin et al., 1987;
Verbeek et al., 1991).
1. The detection rate (DR) of each test: the number of
screened women carrying a true-positive lesion divided
by the total number of screened women.
2. The ratio ofsensitivities (RSe) between the two tests: the
detection rate of the first test divided by the detection
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rate of the second. If the first test is more sensitive, its
detection rate will be higher and, hence, the ratio will
be greater than unity. The McNemar statistics applied
to the discordant women assesses the statistical
significance.
3. The approximated specificity: under the rare disease
assumption, it can be shown that the specificity might
be approximated by the number of negative screening
tests divided by the total number of screened subjects
minus the number of true-positive subjects detected by
the screening test. The index (100 - specificity) indicates
the proportion of non-diseased women found to be
positive by a screening test and thus recalled for
unnecessary work-up procedures.
4. The positive predictive value (PPV) is the number of
women with a screening test truly positive divided by
the total number of women with a positive screening
test (this includes the true-positive and false-positive
results).
Results
In the 4,095 women screened, 24 smear tests (0.6%) and 132
cervicograms (3.2%) were defective. The principal cause of
defect for the smear test was the lack of cellular material on
the slide. For cervicography, defects resulted from the
inability to visualise the cervix (85 women), deficiency of
acetic acid impregnation (35 women) and the over- or under-
exposure of the slides (five women). No information about
the defect was available for the remaining seven cases. When
one of the tests was defective, it was counted as negative. In
21 women, both tests were defective, and thus these women
were excluded from the analysis.
This study population is rather old, with a mean age of 53
years (median 53 years; range 20-79 years).
A total of 222 women (5.4%) had a positive smear and/or
cervicogram (59 positive smear tests and 183 positive cer-
vicograms). Of these, 59 (26.6% of the screen-positive
women) were not assessed in our institute. They were
excluded from the analysis. No difference in the age distribu-
tion existed between those women and the biopsied popula-
tion (data not displayed).
Hence, 4,015 women were retained in the database for the
analysis, 163 (4.1%) with one or two positive screening tests
and 3,852 (95.9%) with two negative screening tests.
Table I displays the results of cytology and cervicography
contrasted with the histopathological results. Among the 163
women who underwent a biopsy, the histopathology
classified 40 as negative, 99 as CIN I, 10 as CIN II, 13 as
CIN III and one invasive carcinoma was included in the
high-grade lesions. Hence, the frequency of true low-grade
lesions is 24.7 per 1,000 screened women, and the frequency
of true high-grade lesions is 6.0 per 1,000 screened
women.
In Table II the results ofcytology are compared with those
of cervicography. Tables Ilal and Hbl concern only the true-
positive lesions and allow the sensitivities to be compared.
The two tests are simultaneously positive only for 10 out of
Tabl I Results of cytology and cervicography. The detection rates
(number of ksions per 1,000 screened women) are in parenthesis
Histopathology
CIN II, III
and carcinoma CIN I Normal Total
Cytology
Positive 14 (3.5) 13 (3.2) 6 33
Negative 10 86 3,886 3,982
Cervicography
Positive 16 (4.0) 90 (22.4) 34 140
Negative 8 9 3,858 3,875
Total 24 (6.0) 99 (24.7) 3,892 4,015
the 163 (6.1%) positive women (Table Ilal). Only one-quarter
of the true high-grade lesions (6/24) were detected by both
tests (Table lIbl). Ten high-grade lesions were missed by the
smear test, and eight by cervicography. These observations
indicate that, to some extent, smear test and cervicography
tend to recognise different women as being positive. So, the
positive results of the less sensitive test (cytology) do not just
constitute a subgroup of the positive results of the more
sensitive test (cervicography).
Tables IIa2 and 11b2 incorporate the screen-negative
results, and the specificities to be compared. There are more
false-positive cervicograms (34) than false-positive smears
(6).
Table III summarises the calculations. The ratios of sensi-
tivities (RSe) and the McNemar statistics indicate that
cervicography is significantly more sensitive than cytology in
detecting cervical lesions: RSe (cervicography versus
cytology) = 3.9. However, the tests seem to detect the same
number of high-grade lesions (14 by cytology, 16 by cervico-
graphy), resulting in an equal sensitivity: RSe (cervicography
versus cytology) = 1.1. Hence, the superiority of cervico-
graphy in detecting cervical lesions is concentrated on the
low-grade lesions, for which the RSe is 6.9 (90/13).
The specificity of cytology is significantly higher in all
circumstances. Cervicography leads to recall of 0.9% of the
women, compared with 0.2% for cytology, i.e. at least four
times more (Table Illa). If only high-grade lesions are con-
sidered (Table IIIb), the specificity of cervicography drops
dramatically, with a low positive predictive value (i.e. most
cervicographically positive women are in fact negative or
have low-grade lesions).
Table IV presents the data with a breakdown by age and
by transformation zone status. This latter parameter is
crucial because most of the dysplasias are initiated in the
transformation zone (TZ). Cervicography, which is a visual
observation method, can assess whether the TZ is totally or
partially visible (i.e. positioned on the ectocervix) or not
visible at all (i.e. it reaches into the endocervical canal). The
TZ status could not be assessed in 133 women (no differences
in age distribution existed between those women and the rest
of the study group).
Table IVa shows that, as age increases, the difference in
sensitivity (expressed as the ratio of sensitivities) between
cytology and cervicography is reduced, and may be reversed,
e.g. in young women cytologically detected high-grade lesions
(four cases) are a subgroup of the cervicographically detected
ones (10 cases), whereas in women aged 55 or more all
high-grade lesions (three cases) were detected by cytology
and none by cervicography.
After stratification according to transformation zone status
(Table IVb and LVc), note that firstly, as age increases, fewer
and fewer women have a visible transformation zone: 76% of
the women under 35 years have a visible TZ compared with
5% of those over 55. Secondly, cervicography detects nearly
Table 11 Contingency tables for comparing results from cytology
and cervicography
Women with a positive Women with a negative
lesion at biopsj biopsy result or with a
(true positives) negative screening test
Cervicographi Cervicographi'
Positive Negative Positive Negative
(a) Truepositive lesionsareanY CINlesions orcarcinoma confirmed
bi histopathologi
Cytology
Positive 10 al 17 0 6
Negative 96 0 34 3,852a
(by Truepositive lesionsare CINIIorIIIlesionsandcarcinomas
confirmedbv histopathologv
Cytology
Positive 6 bi 8 4 b2 15
Negative 10 0 120 3,852a
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Tabk [II Comparison of cinimetric charActeistcs of cytology and cervicography
(computed from data in Tables I and II)
Cytology Cervicography
(a) Truepositive lesionsareany CINlesion orcarcinoma confirewdby
histopathology
Detection rate (per 1,000womenscreened) 6.7 26.4
Ratioofsensitivities(cervicography vscytology) (106/27) = 3.9
NcNemartestforsenstivity X2 = 53.8, P <0.0001
Specificity(%) 99.8 99.1
Positivepredictivevalue(%) 81.8 75.7
NcNemartestforspeificity 2 = 18.2, P <0.0001
(b) Truepositivelesionsare CINIIorIIIksionsandcarcinomaconfimdby
histopathology
Detection rate(per 1,000womenscreened) 3.5 4.0
Ratioofsensitivities(cervicography vs cytology) (16/14)= 1.1
NcNemartestforsensitivity 2 =0.05, P = 0.999
Specificity(%) 99.5 96.9
Positivepredictivevalue (%) 42.4 11.4
NcNemar testforspecifity i = 80.1, P <0.0001
Table IV True-positive lsions detected by each test. Number of women and detection rate per 1,000 women
All true-positive lesions True high-grade lesions only
Number Detected Detected
of women by Detected by by Detected by
Age screened Number cytology cervicography RSea Number cytology cervicography RSe"
(a) All women
20-34 283 31 7 (24.7) 30 (106.0) 4.3 10 4 (14.1) 10 (35-3) 2.5
35-54 1,850 77 15 (8.1) 66 (35.7) 4.4 11 7 (3.8) 6 (3.2) 0.86
S55 1,882 15 5 (2.7) 10 (5.3) 2.0 3 3 (1.6) 0 (0.0) 0
Total 4,015 123 27 (6.7) 106 (26.4) 3.9 24 14 (3.5) 16 (4.0) 1.1
(b) Women with transformation zone (partially or totally) seen at cervicography?
20-34 209 27 5 (23.9) 27 (129.2) 5.4 9 3 (14.3) 9 (42.9) 3.0
35-54 764 53 8 (10.5) 47 (61.5) 5.9 5 2 (2.6) 4 (5.2) 2.0
;55 88 4 1 (11.4) 3 (34.1) 3.0 0 0 (0.0) 0 (0.0) 0.0
1,062 84 14 (16.7) 77 (72.5) 5.5 14 5 (4.7) 13 (12.2) 2.6
(c) Women with transformation zone not seen at cervicograph9O
20-34 64 4 2 (31.2) 3 (47.9) 1.5 1 1 (15.9) 1 (15.9) 1.0
35-54 1,023 24 7 (6.8) 19 (18.6) 2.7 6 5 (4.9) 2 (2.0) 0.4
S55 1,734 11 4 (2.3) 7 (4.0) 1.7 3 3 (1.7) 0 (0.0) 0.0
Total 2,820 39 13 (4.6) 29 (10.3) 2.2 10 9 (3.5) 3 (1.6) 0.3
'RSe, ratio of sensitivities, cervicography vs cytology. 1The transformation zone status could not be asessed for 133 women.
all true high-grade lesions when the transformation zone is
visible (13 cases out of a total of 14), but its sensitivity falls
considerably when the transformation zone disappears into
the cervical canal (three out of a total of ten). This decline in
sensitivity is also evident when considering all true-positive
lesions. Thirdly, by contrast, cytology seems to be more
effective when the TZ is not visible: five high-grade lesions
out of 14 were detected when the TZ was visible, compared
with nine out of ten when the TZ reached the cervical canal.
This explains why, when the TZ is visible, the RSe is in
favour of cervicography (2.6), but drops considerably when
the TZ is in the cervical canal (RSe = 0.3).
The absence of histopathological data for about one-quarter
of the screen-positive women biases the detection rates
towards lower values (the actual detection rate could be
about 25% higher). As a consequence, the PPVs are some-
what underestimated. This flaw could also introduce bias
through age selection: for example young women, who
usually experience higher rates ofcervical sions, are perhaps
less responsive to recall. Although the compliance of our
population was not optimal, the comparison between cyto-
logy and cervicography using the ratios of sensitivities and
the self-matching method is likely to provide a reliable pic-
ture of their merits.
Bearing in mind the relatively high age distribution of this
study group and the mix of prevalent and incident cases, the
detection rates achieved by our cytology compare well with
other published data (Tawa et al., 1988), and the specificty
of our cervicography is much higher: 99.1% vs 95.1% (Staf9,
1981), 90.6% (Tawa et al., 1988) or 94.0% (Szarewski et al.,
1991). This improvement in specificity is essentially due to
the use of a standardied evaluation form (with an evahuation
score), allowing a greater inter-observer agreement.
In the published literature (this study included), postirve
cervicography for any type oflesion is followed by systematic
colposcopy and, eventually, biopsy. In contrast to the con-
clusions of other authors (Tawa et al., 1988; Szarewski et al.,
1991), this use of cervicography does not Lepresent an alter-
native to smear testing for cervical cancer screening
because:
1. The increase in sensitivity essentially applies only to the
low-grade lesions: cervicography detects about 6-7 times
more low-grade lesions than cytology. Even if our smear
test procedure was not optimaly sensitive, this represents
a huge difference. Although the natural course of the
low-grade lesions is still controversiaL they regress spon-
taneously in the vast majority of cass (Miller et al.,
1991). If all patients with low-grade dysplasia are referred
for colposcopy, then the sensitivity of cervicography will128 M. COIBION et al.
overwhelm any current colposcopy programme and result
in overtreatment, with subsequent psychological and
economic impact.
2. In spite of the improvement in specificity, cervicography
still produces significantly more false-positive results,
which has also a great effect on the economic and
psychological cost of the screening programme.
3. Cervicography is more sensitive in younger patients, at
least when the transformation zone is visible. In older
women, cervicography is much less sensitive than smear
tests. Like colposcopy, cervicography produces more
6unsatisfactory and technically defective images' in post-
menopausal women (Jones et al., 1987; Spitzer et al.,
1987).
However, despite the limitations of cervicography, this
study highlights several controversial areas in cervical cancer
screening in which cervicography could be helpful.
Low-grade lesions
Even if the sensitivity of our cytology was not exemplary,
there is no doubt that smear testing leaves many lesions
undetected. It essentially ignores the low-grade lesions, which
are left without work-up procedures or follow-up. This high-
lights the controversy about the marginal benefit (in terms of
invasive cancers avoided) to be gained from the systematic
colposcopic assessment of the low-grade lesions. If even a
small fraction of the low-grade lesions were to evolve into
cancer, then the current screening programmes would be
much less efficient and there would be many more interval
cancers. Our results represent an indirect argument against
the systematic aggressive management of low-grade
lesions.
It is usually recommended that only women with a persis-
tent mild dysplasia on cytology should be referred for colpos-
copy-biopsy (Efiman, 1991). Given the poor sensitivity of
smear tests, the cytological follow-up of low-grade lesions is
at risk of detecting a false-negative result. Colposcopic
studies have already underlined this problem (Jones et al.,
1987; Spitzer et al., 1987). Because of its much higher sen-
sitivity for the detection of low-grade lesions, cervicography
could be effective for the monitoring of low-grade lesions
discovered by cytology among women less than 35 years old.
Given that most low-grade lesions occur in young women,
follow-up with cervicography would perhaps render safer the
'watch-and-do-nothing' policy, and hence represent an accep-
table alternative to systematic colposcopy-biopsy of low-
grade lesions.
High-grade lesions
In young women, cervicography is more sensitive than smear
testing in detecting high-grade lesions, and the high-grade
lesions found by cytology are likely to be a subgroup of
those found by cervicography. Thus, in women less than 35
years old, a single negative cervicography would perhaps
confer higher protection than a single negative smear test.
Nevertheless, before envisaging such a strategy, the specificity
of cervicography must be further increased. Therefore, as for
mammographic screening for breast cancer, the increase in
specificity obtained from a double reading of cervicograms
has to be evaluated.
Quality assurance ofcytological screening
The performance of the smear test is closely linked to the
quality of sampling and reading. Because of its high sen-
sitivity among young women, cervicography may be used for
quality control purposes: for instance, taking cervicograms at
the same time as smears would make it possible to detect
false-negative cytological results. Indeed, the detection of
lesions detected by cervicography but missed by the smear
test would allow identification of failures due to sampling or
reading problems.
CochEjom
Our view of cervicography is less optimistic than that of
other research teams. However, cervicography may comple-
ment smear testing, improving the effectiveness of cervical
screening by allowing a more sensitive detection of high-
grade lesions in young women, and by avoiding the
systematic referral of patients with low-grade lesions for
expensive colposcopy-biopsy procedures. In addition, cervico-
graphy can be considered as an interesting technique for
'minimal lesion' finding, or for studying the transformation
zone status in a large number of women: it could replace
colposcopy for this purpose (Rheder & Blythe, 1988). Larger
prospective studies are needed to evaluate whether these uses
are relevant and economically viable.
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